Company news
Kringle Pharma, Inc. news in 2022
Kringle Pharma, Inc.'s news releases, calls and decks from 2022, newest first.
Update on the Investigator-initiated Phase 2 Study in Patients with ALS
August 12, 2022
Kringle Pharma Files Patent Application for Treatment of Chronic Spinal Cord Injury
March 11, 2022
Kringle Pharma Appoints Hideyuki Okano, M.D., Ph.D. as Scientific Advisor
February 28, 2022
Financial Results for the Three Months Ended December 31, 2021(Non-consolidated)
February 27, 2022